ARROWHEAD PHARMACEUTICALS, INC. (ARWR) insider trading

By person

14 insiders · 64 transactions

337×

Christopher Anzalone holds 337 times base salary in stock. $331.11M of shares against $981.05K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Anzalone last reported holding, valued at $87.30, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Christopher Richard Anzalone

Chief Executive Officer

—

$24.01M (25)

−$24.01M

3,792,739

2.69%

$331.11M

+2.1%

James C Hamilton

Chief Medical Officer

—

$3.93M (9) scheduled

−$3.93M

226,958

0.1607%

$19.81M

+10.8%

Patrick O'Brien

COO

—

$3.12M (12) scheduled

−$3.12M

547,408

0.3875%

$47.79M

+17.9%

Michael S Perry

Director

—

$2.00M (2)

−$2.00M

111,459

0.0789%

$9.73M

−2.9%

Mauro Ferrari

Director

—

$1.02M (2) scheduled

−$1.02M

69,053

0.0489%

$6.03M

+13.6%

Daniel Joseph Apel

Chief Financial Officer

—

$934.29K (3) scheduled

−$934.29K

162,905

0.1153%

$14.22M

+61.3%

Adeoye Y Olukotun

Director

—

$850.54K (4) scheduled

−$850.54K

31,600

0.0224%

$2.76M

+38.3%

Victoria Vakiener

Director

—

$679.49K (3) scheduled

−$679.49K

35,723

0.0253%

$3.12M

+18.3%

William D. Waddill

Director

—

$566.04K (3) scheduled

−$566.04K

56,563

0.0400%

$4.94M

+18.2%

Hongbo Lu

Director

—

$228.33K (1) scheduled

−$228.33K

52,012

0.0368%

$4.54M

+70.9%

Kenneth Allen Myszkowski

Chief Financial Officer

—

455,433

0.3224%

$39.76M

+13.7%

Douglas B Given

Director

—

124,167

0.0879%

$10.84M

−4.3%

Douglas S Ingram

Director

—

46,215

0.0327%

$4.03M

—

Matthew Gregory Cohen

Director

—

11,882

0.0084%

$1.04M

—

ARROWHEAD PHARMACEUTICALS, INC.

What the insiders did Net selling

By person